Advertisement

Index by author

November 2009; Volume 76,Issue 5

A

  1. Allen, John A.

    1. Caveolin-1 and Lipid Microdomains Regulate Gs Trafficking and Attenuate Gs/Adenylyl Cyclase Signaling
      John A. Allen, Jiang Z. Yu, Rahul H. Dave, Anushree Bhatnagar, Bryan L. Roth and Mark M. Rasenick
      Molecular Pharmacology November 2009, 76 (5) 1082-1093; DOI: https://doi.org/10.1124/mol.109.060160

  2. Ambudkar, Suresh V.

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  3. Anguissola, Sergio

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

B

  1. Banerjee, Sreedatta

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  2. Bartlett, David L.

    1. Three Epigenetic Drugs Up-Regulate Homeobox Gene Rhox5 in Cancer Cells through Overlapping and Distinct Molecular Mechanisms
      Qiang Li, David L. Bartlett, Michael C. Gorry, Mark E. O'Malley and Z. Sheng Guo
      Molecular Pharmacology November 2009, 76 (5) 1072-1081; DOI: https://doi.org/10.1124/mol.109.056291

  3. Bastianutto, Carlo

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

  4. Bates, Susan E.

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  5. Beermann, Silke

    1. Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor
      Karl-Friedrich Deml, Silke Beermann, Detlef Neumann, Andrea Strasser and Roland Seifert
      Molecular Pharmacology November 2009, 76 (5) 1019-1030; DOI: https://doi.org/10.1124/mol.109.058651

  6. Beqollari, Donald

    1. Altered G-Protein Coupling in an mGluR6 Point Mutant Associated with Congenital Stationary Night Blindness
      Donald Beqollari, Matthew J. Betzenhauser and Paul J. Kammermeier
      Molecular Pharmacology November 2009, 76 (5) 992-997; DOI: https://doi.org/10.1124/mol.109.058628

  7. Beretta, Matteo

    1. Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
      Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
      Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915

  8. Betzenhauser, Matthew J.

    1. Altered G-Protein Coupling in an mGluR6 Point Mutant Associated with Congenital Stationary Night Blindness
      Donald Beqollari, Matthew J. Betzenhauser and Paul J. Kammermeier
      Molecular Pharmacology November 2009, 76 (5) 992-997; DOI: https://doi.org/10.1124/mol.109.058628

  9. Bhatnagar, Anushree

    1. Caveolin-1 and Lipid Microdomains Regulate Gs Trafficking and Attenuate Gs/Adenylyl Cyclase Signaling
      John A. Allen, Jiang Z. Yu, Rahul H. Dave, Anushree Bhatnagar, Bryan L. Roth and Mark M. Rasenick
      Molecular Pharmacology November 2009, 76 (5) 1082-1093; DOI: https://doi.org/10.1124/mol.109.060160

  10. Bhave, Gautam

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  11. Brueggemann, Lioubov I.

    1. Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles
      Lioubov I. Brueggemann, Alexander R. Mackie, Bharath K. Mani, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology November 2009, 76 (5) 1053-1061; DOI: https://doi.org/10.1124/mol.109.057844

  12. Bui, Peter H.

    1. Functional Characterization of Human Cytochrome P450 2S1 Using a Synthetic Gene-Expressed Protein in Escherichia coli
      Peter H. Bui and Oliver Hankinson
      Molecular Pharmacology November 2009, 76 (5) 1031-1043; DOI: https://doi.org/10.1124/mol.109.057752
    2. Fatty Acid Hydroperoxides Support Cytochrome P450 2S1-Mediated Bioactivation of Benzo[a]pyrene-7,8-dihydrodiol
      Peter H. Bui, Erin L. Hsu and Oliver Hankinson
      Molecular Pharmacology November 2009, 76 (5) 1044-1052; DOI: https://doi.org/10.1124/mol.109.057760

  13. Byron, Kenneth L.

    1. Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles
      Lioubov I. Brueggemann, Alexander R. Mackie, Bharath K. Mani, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology November 2009, 76 (5) 1053-1061; DOI: https://doi.org/10.1124/mol.109.057844

C

  1. Cannon, Mary D.

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

  2. Chakraborty, Arup R.

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  3. Chauder, Brian A.

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  4. Chen, Ching-Shih

    1. Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
      Hany A. Omar, Aaron M. Sargeant, Jing-Ru Weng, Dasheng Wang, Samuel K. Kulp, Tushar Patel and Ching-Shih Chen
      Molecular Pharmacology November 2009, 76 (5) 957-968; DOI: https://doi.org/10.1124/mol.109.058180

  5. Chen, Weiwei

    1. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
      Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
      Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947

  6. Chow, Sue

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

  7. Concannon, Caoimhin G.

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

  8. Courtenay-Luck, Nigel

    1. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
      Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
      Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947

  9. Cribbs, Leanne L.

    1. Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles
      Lioubov I. Brueggemann, Alexander R. Mackie, Bharath K. Mani, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology November 2009, 76 (5) 1053-1061; DOI: https://doi.org/10.1124/mol.109.057844

D

  1. Dave, Rahul H.

    1. Caveolin-1 and Lipid Microdomains Regulate Gs Trafficking and Attenuate Gs/Adenylyl Cyclase Signaling
      John A. Allen, Jiang Z. Yu, Rahul H. Dave, Anushree Bhatnagar, Bryan L. Roth and Mark M. Rasenick
      Molecular Pharmacology November 2009, 76 (5) 1082-1093; DOI: https://doi.org/10.1124/mol.109.060160

  2. Deeken, John F.

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  3. Deml, Karl-Friedrich

    1. Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor
      Karl-Friedrich Deml, Silke Beermann, Detlef Neumann, Andrea Strasser and Roland Seifert
      Molecular Pharmacology November 2009, 76 (5) 1019-1030; DOI: https://doi.org/10.1124/mol.109.058651

  4. Denton, Jerod S.

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  5. Dessauer, Carmen W.

    1. Adenylyl Cyclase–A-kinase Anchoring Protein Complexes: The Next Dimension in cAMP Signaling
      Carmen W. Dessauer
      Molecular Pharmacology November 2009, 76 (5) 935-941; DOI: https://doi.org/10.1124/mol.109.059345

  6. Düssmann, Heiko

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

E

  1. Eloranta, Jyrki J.

    1. Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter
      Jyrki J. Eloranta, Zoulikha M. Zaïr, Christian Hiller, Stephanie Häusler, Bruno Stieger and Gerd A. Kullak-Ublick
      Molecular Pharmacology November 2009, 76 (5) 1062-1071; DOI: https://doi.org/10.1124/mol.109.055392

F

  1. Fallen, Katherine

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  2. Fernandes, Daniel J.

    1. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
      Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
      Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947

  3. Fonseca, Sonali B.

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

G

  1. Gorry, Michael C.

    1. Three Epigenetic Drugs Up-Regulate Homeobox Gene Rhox5 in Cancer Cells through Overlapping and Distinct Molecular Mechanisms
      Qiang Li, David L. Bartlett, Michael C. Gorry, Mark E. O'Malley and Z. Sheng Guo
      Molecular Pharmacology November 2009, 76 (5) 1072-1081; DOI: https://doi.org/10.1124/mol.109.056291

  2. Guo, Z. Sheng

    1. Three Epigenetic Drugs Up-Regulate Homeobox Gene Rhox5 in Cancer Cells through Overlapping and Distinct Molecular Mechanisms
      Qiang Li, David L. Bartlett, Michael C. Gorry, Mark E. O'Malley and Z. Sheng Guo
      Molecular Pharmacology November 2009, 76 (5) 1072-1081; DOI: https://doi.org/10.1124/mol.109.056291

H

  1. Hamdane, Djemel

    1. tert-Butylphenylacetylene Is a Potent Mechanism-Based Inactivator of Cytochrome P450 2B4: Inhibition of Cytochrome P450 Catalysis by Steric Hindrance
      Haoming Zhang, Hsia-lien Lin, Vyvyca J. Walker, Djemel Hamdane and Paul F. Hollenberg
      Molecular Pharmacology November 2009, 76 (5) 1011-1018; DOI: https://doi.org/10.1124/mol.109.059808

  2. Hankinson, Oliver

    1. Functional Characterization of Human Cytochrome P450 2S1 Using a Synthetic Gene-Expressed Protein in Escherichia coli
      Peter H. Bui and Oliver Hankinson
      Molecular Pharmacology November 2009, 76 (5) 1031-1043; DOI: https://doi.org/10.1124/mol.109.057752
    2. Fatty Acid Hydroperoxides Support Cytochrome P450 2S1-Mediated Bioactivation of Benzo[a]pyrene-7,8-dihydrodiol
      Peter H. Bui, Erin L. Hsu and Oliver Hankinson
      Molecular Pharmacology November 2009, 76 (5) 1044-1052; DOI: https://doi.org/10.1124/mol.109.057760

  3. Häusler, Stephanie

    1. Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter
      Jyrki J. Eloranta, Zoulikha M. Zaïr, Christian Hiller, Stephanie Häusler, Bruno Stieger and Gerd A. Kullak-Ublick
      Molecular Pharmacology November 2009, 76 (5) 1062-1071; DOI: https://doi.org/10.1124/mol.109.055392

  4. Hedley, David W.

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

  5. Hiller, Christian

    1. Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter
      Jyrki J. Eloranta, Zoulikha M. Zaïr, Christian Hiller, Stephanie Häusler, Bruno Stieger and Gerd A. Kullak-Ublick
      Molecular Pharmacology November 2009, 76 (5) 1062-1071; DOI: https://doi.org/10.1124/mol.109.055392

  6. Holbeck, Susan

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  7. Hollenberg, Paul F.

    1. tert-Butylphenylacetylene Is a Potent Mechanism-Based Inactivator of Cytochrome P450 2B4: Inhibition of Cytochrome P450 Catalysis by Steric Hindrance
      Haoming Zhang, Hsia-lien Lin, Vyvyca J. Walker, Djemel Hamdane and Paul F. Hollenberg
      Molecular Pharmacology November 2009, 76 (5) 1011-1018; DOI: https://doi.org/10.1124/mol.109.059808

  8. Hsu, Erin L.

    1. Fatty Acid Hydroperoxides Support Cytochrome P450 2S1-Mediated Bioactivation of Benzo[a]pyrene-7,8-dihydrodiol
      Peter H. Bui, Erin L. Hsu and Oliver Hankinson
      Molecular Pharmacology November 2009, 76 (5) 1044-1052; DOI: https://doi.org/10.1124/mol.109.057760

I

  1. Ito, Emma

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

J

  1. Jones, David

    1. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
      Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
      Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947

K

  1. Kammermeier, Paul J.

    1. Altered G-Protein Coupling in an mGluR6 Point Mutant Associated with Congenital Stationary Night Blindness
      Donald Beqollari, Matthew J. Betzenhauser and Paul J. Kammermeier
      Molecular Pharmacology November 2009, 76 (5) 992-997; DOI: https://doi.org/10.1124/mol.109.058628

  2. Katz, David

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

  3. Kelley, Shana O.

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

  4. Koesling, Doris

    1. Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
      Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
      Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915

  5. Kögel, Donat

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

  6. Köhler, Barbara

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

  7. Kullak-Ublick, Gerd A.

    1. Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter
      Jyrki J. Eloranta, Zoulikha M. Zaïr, Christian Hiller, Stephanie Häusler, Bruno Stieger and Gerd A. Kullak-Ublick
      Molecular Pharmacology November 2009, 76 (5) 1062-1071; DOI: https://doi.org/10.1124/mol.109.055392

  8. Kulp, Samuel K.

    1. Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
      Hany A. Omar, Aaron M. Sargeant, Jing-Ru Weng, Dasheng Wang, Samuel K. Kulp, Tushar Patel and Ching-Shih Chen
      Molecular Pharmacology November 2009, 76 (5) 957-968; DOI: https://doi.org/10.1124/mol.109.058180

L

  1. Lewis, L. Michelle

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  2. Li, Qiang

    1. Three Epigenetic Drugs Up-Regulate Homeobox Gene Rhox5 in Cancer Cells through Overlapping and Distinct Molecular Mechanisms
      Qiang Li, David L. Bartlett, Michael C. Gorry, Mark E. O'Malley and Z. Sheng Guo
      Molecular Pharmacology November 2009, 76 (5) 1072-1081; DOI: https://doi.org/10.1124/mol.109.056291

  3. Lin, Hsia-lien

    1. tert-Butylphenylacetylene Is a Potent Mechanism-Based Inactivator of Cytochrome P450 2B4: Inhibition of Cytochrome P450 Catalysis by Steric Hindrance
      Haoming Zhang, Hsia-lien Lin, Vyvyca J. Walker, Djemel Hamdane and Paul F. Hollenberg
      Molecular Pharmacology November 2009, 76 (5) 1011-1018; DOI: https://doi.org/10.1124/mol.109.059808

  4. Lindsley, Craig W.

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  5. Liu, Fei-Fei

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

  6. Lornsen, Katharina A.

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

M

  1. Mackie, Alexander R.

    1. Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles
      Lioubov I. Brueggemann, Alexander R. Mackie, Bharath K. Mani, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology November 2009, 76 (5) 1053-1061; DOI: https://doi.org/10.1124/mol.109.057844

  2. Mani, Bharath K.

    1. Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles
      Lioubov I. Brueggemann, Alexander R. Mackie, Bharath K. Mani, Leanne L. Cribbs and Kenneth L. Byron
      Molecular Pharmacology November 2009, 76 (5) 1053-1061; DOI: https://doi.org/10.1124/mol.109.057844

  3. Mayer, Bernd

    1. Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
      Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
      Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915

  4. Meinkoth, Judy L.

    1. Protein Kinase A and B-Raf Mediate Extracellular Signal-Regulated Kinase Activation by Thyrotropin
      Lisa A. Vuchak, Oxana M. Tsygankova, Gregory V. Prendergast and Judy L. Meinkoth
      Molecular Pharmacology November 2009, 76 (5) 1123-1129; DOI: https://doi.org/10.1124/mol.109.060129

  5. Murray, Frank E.

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

N

  1. Neumann, Detlef

    1. Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor
      Karl-Friedrich Deml, Silke Beermann, Detlef Neumann, Andrea Strasser and Roland Seifert
      Molecular Pharmacology November 2009, 76 (5) 1019-1030; DOI: https://doi.org/10.1124/mol.109.058651

O

  1. O'Byrne, Robert

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

  2. O'Malley, Mark E.

    1. Three Epigenetic Drugs Up-Regulate Homeobox Gene Rhox5 in Cancer Cells through Overlapping and Distinct Molecular Mechanisms
      Qiang Li, David L. Bartlett, Michael C. Gorry, Mark E. O'Malley and Z. Sheng Guo
      Molecular Pharmacology November 2009, 76 (5) 1072-1081; DOI: https://doi.org/10.1124/mol.109.056291

  3. Omar, Hany A.

    1. Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
      Hany A. Omar, Aaron M. Sargeant, Jing-Ru Weng, Dasheng Wang, Samuel K. Kulp, Tushar Patel and Ching-Shih Chen
      Molecular Pharmacology November 2009, 76 (5) 957-968; DOI: https://doi.org/10.1124/mol.109.058180

P

  1. Patel, Tushar

    1. Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
      Hany A. Omar, Aaron M. Sargeant, Jing-Ru Weng, Dasheng Wang, Samuel K. Kulp, Tushar Patel and Ching-Shih Chen
      Molecular Pharmacology November 2009, 76 (5) 957-968; DOI: https://doi.org/10.1124/mol.109.058180

  2. Poonkuzhali, Balasubramanian

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  3. Prehn, Jochen H. M.

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

  4. Prendergast, Gregory V.

    1. Protein Kinase A and B-Raf Mediate Extracellular Signal-Regulated Kinase Activation by Thyrotropin
      Lisa A. Vuchak, Oxana M. Tsygankova, Gregory V. Prendergast and Judy L. Meinkoth
      Molecular Pharmacology November 2009, 76 (5) 1123-1129; DOI: https://doi.org/10.1124/mol.109.060129

R

  1. Rasenick, Mark M.

    1. Caveolin-1 and Lipid Microdomains Regulate Gs Trafficking and Attenuate Gs/Adenylyl Cyclase Signaling
      John A. Allen, Jiang Z. Yu, Rahul H. Dave, Anushree Bhatnagar, Bryan L. Roth and Mark M. Rasenick
      Molecular Pharmacology November 2009, 76 (5) 1082-1093; DOI: https://doi.org/10.1124/mol.109.060160

  2. Redha, Rey

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  3. Rehm, Markus

    1. Bid and Calpains Cooperate to Trigger Oxaliplatin-Induced Apoptosis of Cervical Carcinoma HeLa Cells
      Sergio Anguissola, Barbara Köhler, Robert O'Byrne, Heiko Düssmann, Mary D. Cannon, Frank E. Murray, Caoimhin G. Concannon, Markus Rehm, Donat Kögel and Jochen H. M. Prehn
      Molecular Pharmacology November 2009, 76 (5) 998-1010; DOI: https://doi.org/10.1124/mol.109.058156

  4. Riffel, Amanda K.

    1. Regulation of the CYP3A4 and CYP3A7 Promoters by Members of the Nuclear Factor I Transcription Factor Family
      Amanda K. Riffel, Eric Schuenemann and Carrie A. Vyhlidal
      Molecular Pharmacology November 2009, 76 (5) 1104-1114; DOI: https://doi.org/10.1124/mol.109.055699

  5. Robey, Robert W.

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  6. Roth, Bryan L.

    1. Caveolin-1 and Lipid Microdomains Regulate Gs Trafficking and Attenuate Gs/Adenylyl Cyclase Signaling
      John A. Allen, Jiang Z. Yu, Rahul H. Dave, Anushree Bhatnagar, Bryan L. Roth and Mark M. Rasenick
      Molecular Pharmacology November 2009, 76 (5) 1082-1093; DOI: https://doi.org/10.1124/mol.109.060160

  7. Russwurm, Michael

    1. Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
      Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
      Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915

S

  1. Sargeant, Aaron M.

    1. Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
      Hany A. Omar, Aaron M. Sargeant, Jing-Ru Weng, Dasheng Wang, Samuel K. Kulp, Tushar Patel and Ching-Shih Chen
      Molecular Pharmacology November 2009, 76 (5) 957-968; DOI: https://doi.org/10.1124/mol.109.058180

  2. Schimmer, Aaron D.

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

  3. Schmidt, Kurt

    1. Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
      Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
      Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915

  4. Schuenemann, Eric

    1. Regulation of the CYP3A4 and CYP3A7 Promoters by Members of the Nuclear Factor I Transcription Factor Family
      Amanda K. Riffel, Eric Schuenemann and Carrie A. Vyhlidal
      Molecular Pharmacology November 2009, 76 (5) 1104-1114; DOI: https://doi.org/10.1124/mol.109.055699

  5. Schuetz, Erin G.

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  6. Seifert, Roland

    1. Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor
      Karl-Friedrich Deml, Silke Beermann, Detlef Neumann, Andrea Strasser and Roland Seifert
      Molecular Pharmacology November 2009, 76 (5) 1019-1030; DOI: https://doi.org/10.1124/mol.109.058651

  7. Shapiro, Mark S.

    1. An Ion Channel Hypothesis to Explain Divergent Cardiovascular Safety of Cyclooxygenase-2 Inhibitors: The Answer to a Hotly Debated Puzzle?
      Mark S. Shapiro
      Molecular Pharmacology November 2009, 76 (5) 942-945; DOI: https://doi.org/10.1124/mol.109.059683

  8. Shukla, Suneet

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  9. Soundararajan, Sridharan

    1. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
      Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
      Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947

  10. Spicer, Eleanor K.

    1. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
      Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
      Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947

  11. Sridharan, Vijayalakshmi

    1. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
      Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
      Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947

  12. Steadman, Kenneth

    1. Identification of Compounds that Correlate with ABCG2 Transporter Function in the National Cancer Institute Anticancer Drug Screen
      John F. Deeken, Robert W. Robey, Suneet Shukla, Kenneth Steadman, Arup R. Chakraborty, Balasubramanian Poonkuzhali, Erin G. Schuetz, Susan Holbeck, Suresh V. Ambudkar and Susan E. Bates
      Molecular Pharmacology November 2009, 76 (5) 946-956; DOI: https://doi.org/10.1124/mol.109.056192

  13. Stessel, Heike

    1. Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
      Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
      Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915

  14. Stieger, Bruno

    1. Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter
      Jyrki J. Eloranta, Zoulikha M. Zaïr, Christian Hiller, Stephanie Häusler, Bruno Stieger and Gerd A. Kullak-Ublick
      Molecular Pharmacology November 2009, 76 (5) 1062-1071; DOI: https://doi.org/10.1124/mol.109.055392

  15. Strasser, Andrea

    1. Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor
      Karl-Friedrich Deml, Silke Beermann, Detlef Neumann, Andrea Strasser and Roland Seifert
      Molecular Pharmacology November 2009, 76 (5) 1019-1030; DOI: https://doi.org/10.1124/mol.109.058651

T

  1. Tsygankova, Oxana M.

    1. Protein Kinase A and B-Raf Mediate Extracellular Signal-Regulated Kinase Activation by Thyrotropin
      Lisa A. Vuchak, Oxana M. Tsygankova, Gregory V. Prendergast and Judy L. Meinkoth
      Molecular Pharmacology November 2009, 76 (5) 1123-1129; DOI: https://doi.org/10.1124/mol.109.060129

V

  1. Vuchak, Lisa A.

    1. Protein Kinase A and B-Raf Mediate Extracellular Signal-Regulated Kinase Activation by Thyrotropin
      Lisa A. Vuchak, Oxana M. Tsygankova, Gregory V. Prendergast and Judy L. Meinkoth
      Molecular Pharmacology November 2009, 76 (5) 1123-1129; DOI: https://doi.org/10.1124/mol.109.060129

  2. Vyhlidal, Carrie A.

    1. Regulation of the CYP3A4 and CYP3A7 Promoters by Members of the Nuclear Factor I Transcription Factor Family
      Amanda K. Riffel, Eric Schuenemann and Carrie A. Vyhlidal
      Molecular Pharmacology November 2009, 76 (5) 1104-1114; DOI: https://doi.org/10.1124/mol.109.055699

W

  1. Walker, Vyvyca J.

    1. tert-Butylphenylacetylene Is a Potent Mechanism-Based Inactivator of Cytochrome P450 2B4: Inhibition of Cytochrome P450 Catalysis by Steric Hindrance
      Haoming Zhang, Hsia-lien Lin, Vyvyca J. Walker, Djemel Hamdane and Paul F. Hollenberg
      Molecular Pharmacology November 2009, 76 (5) 1011-1018; DOI: https://doi.org/10.1124/mol.109.059808

  2. Wang, Dasheng

    1. Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
      Hany A. Omar, Aaron M. Sargeant, Jing-Ru Weng, Dasheng Wang, Samuel K. Kulp, Tushar Patel and Ching-Shih Chen
      Molecular Pharmacology November 2009, 76 (5) 957-968; DOI: https://doi.org/10.1124/mol.109.058180

  3. Wang, Li

    1. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
      Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel Courtenay-Luck, David Jones, Eleanor K. Spicer and Daniel J. Fernandes
      Molecular Pharmacology November 2009, 76 (5) 984-991; DOI: https://doi.org/10.1124/mol.109.055947

  4. Weaver, C. David

    1. High-Throughput Screening Reveals a Small-Molecule Inhibitor of the Renal Outer Medullary Potassium Channel and Kir7.1
      L. Michelle Lewis, Gautam Bhave, Brian A. Chauder, Sreedatta Banerjee, Katharina A. Lornsen, Rey Redha, Katherine Fallen, Craig W. Lindsley, C. David Weaver and Jerod S. Denton
      Molecular Pharmacology November 2009, 76 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.109.059840

  5. Weng, Jing-Ru

    1. Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
      Hany A. Omar, Aaron M. Sargeant, Jing-Ru Weng, Dasheng Wang, Samuel K. Kulp, Tushar Patel and Ching-Shih Chen
      Molecular Pharmacology November 2009, 76 (5) 957-968; DOI: https://doi.org/10.1124/mol.109.058180

  6. Wenzl, M. Verena

    1. Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
      Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
      Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915

  7. Wood, Tabitha E.

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

X

  1. Xu, G. Wei

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

Y

  1. Yip, Kenneth W.

    1. Potential Use of Cetrimonium Bromide as an Apoptosis-Promoting Anticancer Agent for Head and Neck Cancer
      Emma Ito, Kenneth W. Yip, David Katz, Sonali B. Fonseca, David W. Hedley, Sue Chow, G. Wei Xu, Tabitha E. Wood, Carlo Bastianutto, Aaron D. Schimmer, Shana O. Kelley and Fei-Fei Liu
      Molecular Pharmacology November 2009, 76 (5) 969-983; DOI: https://doi.org/10.1124/mol.109.055277

  2. Yu, Jiang Z.

    1. Caveolin-1 and Lipid Microdomains Regulate Gs Trafficking and Attenuate Gs/Adenylyl Cyclase Signaling
      John A. Allen, Jiang Z. Yu, Rahul H. Dave, Anushree Bhatnagar, Bryan L. Roth and Mark M. Rasenick
      Molecular Pharmacology November 2009, 76 (5) 1082-1093; DOI: https://doi.org/10.1124/mol.109.060160

Z

  1. Zaïr, Zoulikha M.

    1. Vitamin D3 and Its Nuclear Receptor Increase the Expression and Activity of the Human Proton-Coupled Folate Transporter
      Jyrki J. Eloranta, Zoulikha M. Zaïr, Christian Hiller, Stephanie Häusler, Bruno Stieger and Gerd A. Kullak-Ublick
      Molecular Pharmacology November 2009, 76 (5) 1062-1071; DOI: https://doi.org/10.1124/mol.109.055392

  2. Zeller, Andreas

    1. Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt
      Andreas Zeller, M. Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt and Bernd Mayer
      Molecular Pharmacology November 2009, 76 (5) 1115-1122; DOI: https://doi.org/10.1124/mol.109.059915

  3. Zhang, Haoming

    1. tert-Butylphenylacetylene Is a Potent Mechanism-Based Inactivator of Cytochrome P450 2B4: Inhibition of Cytochrome P450 Catalysis by Steric Hindrance
      Haoming Zhang, Hsia-lien Lin, Vyvyca J. Walker, Djemel Hamdane and Paul F. Hollenberg
      Molecular Pharmacology November 2009, 76 (5) 1011-1018; DOI: https://doi.org/10.1124/mol.109.059808
Back to top

In this issue